TED public contract notices · Public Contracts
Germany – Pharmaceutical products – Vereinbarung nach § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Bevacizumab gamma (Lytenava™)
Official identifier 330176-2025
IrelandContract
- Buyer
- AOK Baden-Württemberg
- Winner
- Outlook Therapeutics Limited
- Contract
- Auftrag Bevacizumab gamma
- Lot
- LOT-0001
- Published value
- 221,000
- Currency
- EUR
- Official notice
- https://ted.europa.eu/en/notice/330176-2025
Linked company
Company: OUTLOOK THERAPEUTICS LIMITED
Official identifier: 727775